OSEBX1,423.56+0.84%
EQNR284.60+4.20%
DNB198.35-1.15%
MOWI172.80+0.45%
Brent$71.24-0.32%
EUR/USD1.0824-0.14%
DXY104.18+0.08%
INDICATIVE · SAMPLE DATA
082956

Shenguan Holdings (Group) Ltd

Food ProcessingVerified

Shenguan Holdings exhibits a strong liquidity position with a current ratio of 2.61, indicating the company can cover its short-term liabilities more than twice over with its current assets. The company holds CNY 533.85 million in cash and equivalents, which is a significant portion of its total assets of CNY 2.76 billion. The debt-to-equity ratio of 0.19 suggests a conservative capital structure with limited leverage, reducing financial risk exposure. Profitability metrics, however, are negative. The company reported a net loss of CNY 69.77 million and an operating loss of CNY 28.64 million in the latest period. Return on equity (ROE) and return on assets (ROA) are -3.28% and -2.52%, respectively, indicating poor capital efficiency and asset utilization. These figures fall below the typical performance benchmarks for the Food Processing industry, which usually expects positive ROE and ROA figures for sustainable operations. The company's revenue is primarily derived from collagen-based products and maternal-infant offerings, with a focus on both domestic and overseas markets. However, the input data does not provide specific segment or geographic revenue breakdowns, making it difficult to assess concentration risk or growth drivers in detail. Without disclosed segment data, it is unclear whether the company is over-reliant on a single product line or geographic region. Looking ahead, the company's growth trajectory is uncertain. The latest financial data does not include forward-looking revenue guidance or historical growth rates, which are essential for assessing future performance. The absence of a clear growth narrative, combined with current operating losses, raises concerns about the company's ability to scale profitably in the near term. Risk factors include the company's negative net income and operating income, which could pressure liquidity if cash burn accelerates. The risk assessment indicates low dilution and liquidity risk, with no immediate filing-based flags detected. However, the company's current financial performance suggests a need for close monitoring of cash flow and capital preservation strategies. Recent events, such as filings or transcripts, are not detailed in the input data, limiting the ability to assess management commentary or strategic shifts. The lack of recent disclosures may indicate limited transparency or a focus on internal operations rather than public communication.

30-day price · 0829-0.02 (-11.4%)
Low$0.15High$0.20Close$0.16As of22 May, 00:00 UTC
Profile
CompanyShenguan Holdings (Group) Ltd
Ticker0829.HK
SectorConsumer Non-Cyclicals
BusinessFood & Beverages
Industry groupFood & Beverages
IndustryFood Processing
AI analysis

Business. Shenguan Holdings (Group) Ltd is an investment holding company primarily engaged in the collagen products business, including edible collagen sausage casing products, collagen food products, collagen skin care products, and polymer collagen medical biomaterials, as well as the provision of maternal-infant products.

Classification. Shenguan Holdings is classified under the Consumer Non-Cyclicals economic sector, Food & Beverages business sector, and Food Processing industry, with a classification confidence of 0.92.

Shenguan Holdings exhibits a strong liquidity position with a current ratio of 2.61, indicating the company can cover its short-term liabilities more than twice over with its current assets. The company holds CNY 533.85 million in cash and equivalents, which is a significant portion of its total assets of CNY 2.76 billion. The debt-to-equity ratio of 0.19 suggests a conservative capital structure with limited leverage, reducing financial risk exposure. Profitability metrics, however, are negative. The company reported a net loss of CNY 69.77 million and an operating loss of CNY 28.64 million in the latest period. Return on equity (ROE) and return on assets (ROA) are -3.28% and -2.52%, respectively, indicating poor capital efficiency and asset utilization. These figures fall below the typical performance benchmarks for the Food Processing industry, which usually expects positive ROE and ROA figures for sustainable operations. The company's revenue is primarily derived from collagen-based products and maternal-infant offerings, with a focus on both domestic and overseas markets. However, the input data does not provide specific segment or geographic revenue breakdowns, making it difficult to assess concentration risk or growth drivers in detail. Without disclosed segment data, it is unclear whether the company is over-reliant on a single product line or geographic region. Looking ahead, the company's growth trajectory is uncertain. The latest financial data does not include forward-looking revenue guidance or historical growth rates, which are essential for assessing future performance. The absence of a clear growth narrative, combined with current operating losses, raises concerns about the company's ability to scale profitably in the near term. Risk factors include the company's negative net income and operating income, which could pressure liquidity if cash burn accelerates. The risk assessment indicates low dilution and liquidity risk, with no immediate filing-based flags detected. However, the company's current financial performance suggests a need for close monitoring of cash flow and capital preservation strategies. Recent events, such as filings or transcripts, are not detailed in the input data, limiting the ability to assess management commentary or strategic shifts. The lack of recent disclosures may indicate limited transparency or a focus on internal operations rather than public communication.
Key takeaways
  • Shenguan Holdings has a strong liquidity position with a current ratio of 2.61 and CNY 533.85 million in cash and equivalents.
  • The company is currently unprofitable, with a net loss of CNY 69.77 million and an operating loss of CNY 28.64 million.
  • Return on equity and return on assets are negative at -3.28% and -2.52%, respectively, indicating poor capital efficiency.
  • The company's capital structure is conservative, with a debt-to-equity ratio of 0.19.
  • Revenue concentration and geographic exposure are not disclosed, limiting visibility into potential risks.
  • No immediate liquidity or dilution risks are flagged, but the company's financial performance requires close monitoring.
  • --
  • ## RATIONALES
Financial snapshot
PeriodHA-latest
CurrencyCNY
Revenue$1.02B
Gross profit$104.7M
Operating income-$28.6M
Net income-$69.8M
R&D
SG&A
D&A
SBC
Operating cash flow
CapEx
Free cash flow
Total assets$2.76B
Total liabilities$637.9M
Total equity$2.13B
Cash & equivalents$533.8M
Long-term debt$405.9M
Annual history (last 5)
PeriodRevenueOp IncomeNet IncomeFCF
FY0
FY-1
FY-2
FY-3
FY-4
PeriodGross %Op %Net %FCF %
FY0
FY-1
FY-2
FY-3
FY-4
PeriodAssetsEquityCashDebt
FY0
FY-1
FY-2
FY-3
FY-4
PeriodOCFCapExFCFSBC
FY0
FY-1
FY-2
FY-3
FY-4
Quarterly history (last 4)
PeriodRevenueOp IncomeNet IncomeFCF
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
PeriodGross %Op %Net %FCF %
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
PeriodAssetsEquityCashDebt
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
PeriodOCFCapExFCFSBC
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
Valuation
Market price
Market cap
Enterprise value
P/E
Reported non-GAAP P/E
EV/Revenue
EV/Op income
EV/OCF
P/B
P/Tangible book
Tangible book$2.13B
Net cash$128.0M
Current ratio2.6
Debt/Equity0.2
ROA-2.5%
ROE-3.3%
Cash conversion
CapEx/Revenue
SBC/Revenue
Asset intensity
Dilution ratio0.0%
Risk assessment
Dilution riskLow
Liquidity riskLow
  • No immediate filing-based liquidity or dilution flags were detected.
Industry benchmarks
Activity: Food Processing · cohort 6 companies
Metric0829Activity
Op margin-2.8%3.3% medp25 2.5% · p75 4.5%bottom quartile
Net margin-6.8%3.0% medp25 1.5% · p75 6.7%bottom quartile
Gross margin10.2%24.0% medp25 20.2% · p75 35.3%bottom quartile
R&D / revenue0.8% medp25 0.5% · p75 2.3%
CapEx / revenue5.2% medp25 4.8% · p75 5.7%
Debt / equity19.0%33.5% medp25 29.1% · p75 81.5%bottom quartile
Source data
Underlying data the analysis-pipeline pulls and audits. Fetch timestamps + content hashes show when each source was last refreshed.
Company fundamentalsperiod FQ-7 · history via verified-market-data
no public URL
2026-05-10 08:07 UTC#bed62469
Market quoteclose CNY 0.19 · shares 3.23B diluted
no public URL
2026-05-05 20:14 UTC#ffafc6cb
Source: analysis-pipeline (hybrid)Generated: 2026-05-10 08:09 UTCJob: 4b0ffa82